There have not been major advancements in bladder cancer over the last few decades: survival has remained stagnant and there continues to be a lack of approved therapies. Therefore, there are several areas of improvement in the field of bladder cancer, Richards explains.

For the future, Richard envisions more targeted therapies being available for patients. There is promising data from the Cancer Genome Atlas, which shows that researchers can individualize each patient’s bladder cancer and tailor treatments to those patients.

There have not been major advancements in bladder cancer over the last few decades: survival has remained stagnant and there continues to be a lack of approved therapies. Therefore, there are several areas of improvement in the field of bladder cancer, Richards explains.

For the future, Richard envisions more targeted therapies being available for patients. There is promising data from the Cancer Genome Atlas, which shows that researchers can individualize each patient’s bladder cancer and tailor treatments to those patients.